These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29234909)

  • 1. An era of biological treatment in systemic lupus erythematosus.
    He J; Li Z
    Clin Rheumatol; 2018 Jan; 37(1):1-3. PubMed ID: 29234909
    [No Abstract]   [Full Text] [Related]  

  • 2. The uncertain pathway to new therapeutics for SLE.
    Lipsky PE
    Nat Clin Pract Rheumatol; 2009 Feb; 5(2):61. PubMed ID: 19182810
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT; Houghton K; Bond M; Senger C; Tucker LB
    J Rheumatol; 2010 Aug; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract]   [Full Text] [Related]  

  • 4. New therapies for systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Clin Exp Immunol; 2005 May; 140(2):205-12. PubMed ID: 15807843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological treatment of rare inflammatory rheumatic diseases].
    Baslund B
    Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab and lupus interstitial lung disease: friend or foe?
    Efthimiou P; Kukar M; Hersh A
    Int J Rheum Dis; 2011 Feb; 14(1):e3-4. PubMed ID: 21303472
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal manifestations of rheumatological disorders.
    Biswas S; Paul R
    J Indian Med Assoc; 2013 Aug; 111(8):542-4, 552. PubMed ID: 24783393
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?
    Anolik J
    J Rheumatol; 2011 Apr; 38(4):587-9. PubMed ID: 21459953
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic lupus erythematosus: modern strategies for management: a moving target.
    King JK; Hahn BH
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):971-87. PubMed ID: 18068856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in treatment of systemic lupus erythematosus].
    Wang Q; Zhang X
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):161-4. PubMed ID: 23751573
    [No Abstract]   [Full Text] [Related]  

  • 13. Reconsidering antimalarials in systemic lupus erythematosus: developments of translational clinical interest.
    Venuturupalli S; Gudsoorkar V; Wallace D
    J Rheumatol; 2012 Sep; 39(9):1769-71. PubMed ID: 22942300
    [No Abstract]   [Full Text] [Related]  

  • 14. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
    Fanouriakis A; Mastorodemos V; Pamfil C; Papadaki E; Sidiropoulos P; Plaitakis A; Amoiridis G; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2014 Jun; 43(6):751-8. PubMed ID: 24332007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutical perspectives in systemic lupus erythematosus].
    Cervera R; Font J
    Med Clin (Barc); 2004 Oct; 123(14):540-2. PubMed ID: 15535928
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent progress in conventional and biologic therapy for systemic lupus erythematosus.
    Wofsy D
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii66-8. PubMed ID: 23253930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in systemic lupus erythematosus.
    Abud-Mendoza C; González-Amaro R
    Lupus; 2010 Apr; 19(5):658. PubMed ID: 19900978
    [No Abstract]   [Full Text] [Related]  

  • 18. New immune modulatory drugs for systemic lupus erythematosus--what can we expect?
    Davidson A
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):638-9. PubMed ID: 17133245
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.
    Kittaka K; Dobashi H; Baba N; Iseki K; Kameda T; Susaki K; Kitanaka A; Kubota Y; Ishida T
    Scand J Rheumatol; 2008; 37(5):390-3. PubMed ID: 18609263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticytokine therapy in systemic lupus erythematosus.
    Yoo DH
    Lupus; 2010 Oct; 19(12):1460-7. PubMed ID: 20947558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.